Celsius (CELH) Stock Forecast, Price & News

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Celsius in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CELH shares.
View CELH analyst ratings or view top-rated stocks.

7 Wall Street analysts have issued 1 year price targets for Celsius' shares. Their CELH share price forecasts range from $120.00 to $160.00. On average, they expect the company's share price to reach $135.11 in the next twelve months. This suggests that the stock has a possible downside of 2.2%.
View analysts price targets for CELH or view top-rated stocks among Wall Street analysts.

Celsius' stock was trading at $104.04 on January 1st, 2023. Since then, CELH stock has increased by 32.8% and is now trading at $138.17.
View the best growth stocks for 2023 here.

Celsius saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 10,440,000 shares, an increase of 5.6% from the April 30th total of 9,890,000 shares. Based on an average daily trading volume, of 1,090,000 shares, the days-to-cover ratio is presently 9.6 days. Currently, 24.6% of the shares of the stock are short sold.
View Celsius' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our CELH earnings forecast.

Celsius Holdings, Inc. (NASDAQ:CELH) issued its quarterly earnings results on Tuesday, May, 9th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.22 by $0.18. The company earned $259.94 million during the quarter, compared to analyst estimates of $219.58 million. Celsius had a positive trailing twelve-month return on equity of 9.01% and a negative net margin of 19.58%. Celsius's revenue was up 94.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.09 EPS.

ETFs with the largest weight of Celsius (NASDAQ:CELH) stock in their portfolio include VegTech Plant-based Innovation & Climate ETF (EATV), Global X Health & Wellness ETF (BFIT), Future Fund Active ETF (FFND), Invesco Dynamic Food & Beverage ETF (PBJ), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Strategas Macro Thematic Opportunities ETF (SAMT), First Trust Multi-Manager Small Cap Opportunities ETF (MMSC) and Fidelity Blue Chip Growth ETF (FBCG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Celsius investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Block (SQ), AbbVie (ABBV), Pfizer (PFE), Applied Materials (AMAT), Gilead Sciences (GILD), PayPal (PYPL) and Cisco Systems (CSCO).

Celsius trades on the NASDAQ under the ticker symbol "CELH."

Celsius' stock is owned by a variety of retail and institutional investors. Top institutional investors include FMR LLC (11.37%), BlackRock Inc. (6.74%), Wellington Management Group LLP (2.19%), State Street Corp (2.04%), Eagle Asset Management Inc. (1.51%) and American Century Companies Inc. (1.29%). Insiders that own company stock include Carl Desantis, Caroline S Levy, Hal Kravitz, Hoi Shuen Solina Holly Chau, John Fieldly, Nicholas Castaldo and William H Milmoe.
View institutional ownership trends.

Shares of CELH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CELH stock can currently be purchased for approximately $138.17.

Celsius (NASDAQ:CELH) has a market capitalization of $10.50 billion and generates $653.60 million in revenue each year. The company earns $-187,280,000.00 in net income (profit) each year or ($2.31) on an earnings per share basis.

The company employs 225 workers across the globe.

Celsius' mailing address is 2424 NORTH FEDERAL HIGHWAY SUITE 208, BOCA RATON FL, 33431. The official website for the company is www.celsiusholdingsinc.com. The company can be reached via phone at (561) 276-2239, via email at ir@ampliphibio.com, or via fax at 561-276-2268.